LongBio Pharma Sets 21 August 2026 Board Meeting to Review 1H26 Results and Potential Dividend

Bulletin Express

08/11

LongBio Pharma (Suzhou) Co., Ltd. has scheduled a board meeting for Friday, 21 August 2026. The agenda includes approval of the unaudited interim results for the six months ended 30 June 2026 and consideration of an interim dividend distribution.

The announcement, dated 11 August 2026, confirms that any dividend decision will be determined at the upcoming session.

As of the announcement date, the Board comprises 11 directors: three executive directors (Dr. Liu Heng, Dr. Sun Bill Nai-chau and Mr. Xie Ming), four non-executive directors (Mr. Lin Jian, Ms. Gu Qin, Dr. Xue Di and Dr. Chen Kan) and four independent non-executive directors (Mr. Siu Paul Yu Hay, Mr. Ruan Tim, Mr. Yang Chun and Mr. Zhou Guofang).

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1177059964"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1177059964\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1177059964?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-11 18:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1177059964","market":"us","top_or_hot":-1,"title":"LongBio Pharma Sets 21 August 2026 Board Meeting to Review 1H26 Results and Potential Dividend","media":"Bulletin Express","content":"<p>LongBio Pharma (Suzhou) Co., Ltd. has scheduled a board meeting for Friday, 21 August 2026. The agenda includes approval of the unaudited interim results for the six months ended 30 June 2026 and consideration of an interim dividend distribution.</p>\n<p>The announcement, dated 11 August 2026, confirms that any dividend decision will be determined at the upcoming session.</p>\n<p>As of the announcement date, the Board comprises 11 directors: three executive directors (Dr. Liu Heng, Dr. Sun Bill Nai-chau and Mr. Xie Ming), four non-executive directors (Mr. Lin Jian, Ms. Gu Qin, Dr. Xue Di and Dr. Chen Kan) and four independent non-executive directors (Mr. Siu Paul Yu Hay, Mr. Ruan Tim, Mr. Yang Chun and Mr. Zhou Guofang).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LongBio Pharma Sets 21 August 2026 Board Meeting to Review 1H26 Results and Potential Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLongBio Pharma Sets 21 August 2026 Board Meeting to Review 1H26 Results and Potential Dividend\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-08-11 18:23</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>LongBio Pharma (Suzhou) Co., Ltd. has scheduled a board meeting for Friday, 21 August 2026. The agenda includes approval of the unaudited interim results for the six months ended 30 June 2026 and consideration of an interim dividend distribution.</p>\n<p>The announcement, dated 11 August 2026, confirms that any dividend decision will be determined at the upcoming session.</p>\n<p>As of the announcement date, the Board comprises 11 directors: three executive directors (Dr. Liu Heng, Dr. Sun Bill Nai-chau and Mr. Xie Ming), four non-executive directors (Mr. Lin Jian, Ms. Gu Qin, Dr. Xue Di and Dr. Chen Kan) and four independent non-executive directors (Mr. Siu Paul Yu Hay, Mr. Ruan Tim, Mr. Yang Chun and Mr. Zhou Guofang).</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01779","symbol_name":"天辰生物-B","start_time":0,"source_url":"","article_id":"1177059964","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1177059964","pubTimestamp":1786443829,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"LongBio Pharma (Suzhou) Co., Ltd. has scheduled a board meeting for Friday, 21 August 2026. The agenda includes approval of the unaudited interim results for the six months ended 30 June 2026 and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01779":"天辰生物-B"},"translate_title":"龙生物医药定于 2026 年 8 月 21 日召开董事会会议，审查 26 年上半年业绩和潜在股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01779":1},"content_text":"LongBio Pharma (Suzhou) Co., Ltd. has scheduled a board meeting for Friday, 21 August 2026. The agenda includes approval of the unaudited interim results for the six months ended 30 June 2026 and consideration of an interim dividend distribution.\nThe announcement, dated 11 August 2026, confirms that any dividend decision will be determined at the upcoming session.\nAs of the announcement date, the Board comprises 11 directors: three executive directors (Dr. Liu Heng, Dr. Sun Bill Nai-chau and Mr. Xie Ming), four non-executive directors (Mr. Lin Jian, Ms. Gu Qin, Dr. Xue Di and Dr. Chen Kan) and four independent non-executive directors (Mr. Siu Paul Yu Hay, Mr. Ruan Tim, Mr. Yang Chun and Mr. Zhou Guofang).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}